학술논문

Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial
Document Type
Article
Source
In Annals of Oncology January 2015 26(1):132-140
Subject
Language
ISSN
0923-7534